Provider considerations for navigating vertical integration challenges
Vertical integration has reshaped U.S. health care over the past decade, pulling insurers, physicians, pharmacies and pharmacy benefit managers into single corporate structures. What began as a push for better coordination and efficiency is now under bipartisan scrutiny, with providers increasingly caught between payer strategy and policy risk.
That tension was on display recently when health insurance CEOs testified before Congress. Lawmakers questioned whether consolidation has delivered on its promises or instead reduced competition, limited patient choice and driven higher costs. While insurers argue that owning more of the care continuum improves outcomes and lowers friction, critics point to patient steering, opaque pricing and mounting pressure on independent practices.
For providers, vertical integration is not an abstract policy issue. Ownership structures shape referral patterns, reimbursement dynamics and clinical autonomy. When insurers own physician groups, it’s likely referrals default to system‑owned hospitals and outpatient departments, even when lower‑cost or more convenient options exist. This “mothership” effect sometimes shifts care into higher‑priced settings and constrains independent decision‑making.
And, sometimes, regulatory mechanics reinforce the model. Under the Affordable Care Act, insurers spend at least 85% of premium revenue on medical care. Payments to owned clinics, pharmacies or pharmacy benefit managers count toward that threshold—even when they include embedded profit—allowing integrated firms to comply with regulation while retaining revenue internally. Independent providers, meanwhile, often face tighter reimbursement and diminished negotiating leverage.
The evidence supporting vertical integration remains mixed. Research shows modest and inconsistent improvements in quality, but persistent increases in prices, sometimes driven by care migrating to more expensive hospital outpatient settings. Independent physician‑led accountable care organizations, by contrast, have demonstrated stronger cost performance than hospital‑integrated models. That evidence is likely shaping federal policy, including the Centers for Medicare & Medicaid Services model launching in 2027, which is explicitly designed to support independent, rural and specialty practices.
For providers, preparation matters more than prediction.
Independent practices should focus on scale without surrendering control. Clinically integrated networks and physician‑led accountable care organizations allow groups to pool contracting power, invest in analytics and care management, and to participate in value‑based reimbursement while maintaining autonomy. As payers face growing scrutiny, performance‑based contracting is likely to matter more than ownership alignment.
Providers employed by integrated systems should engage in scenario planning. Over half of U.S. physicians are employed by hospital-owned practices that may rely on system‑provided IT platforms, data infrastructure and administrative support. While forced divestitures remain unlikely, heightened regulatory pressure could still disrupt referral flows, contracting strategies and care delivery models. Understanding how practices would operate if ownership or payer behavior changes is increasingly important.
The takeaway
For providers, the risk is not whether vertical integration survives, but whether reliance on it limits future options. Regulatory scrutiny is already changing payer behavior, placing greater emphasis on measurable value, transparency and cost control. Providers that invest now in value‑based capabilities, flexible partnerships and independence‑friendly operating models will be better positioned to navigate policy uncertainty.
Learn more about what’s happening in health care in our industry outlook.
